Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-11-2014 | Original Article

¹⁸F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study

Authors: Luka Lezaic, Sebastijan Rep, Mojca Jensterle Sever, Tomaz Kocjan, Marko Hocevar, Jure Fettich

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 11/2014

Abstract

Purpose

Primary hyperparathyroidism is a common endocrine disorder which is diagnosed biochemically and for which therapy is surgical. A prerequisite for minimally invasive surgery, which minimizes morbidity and cost, is accurate localization of the involved gland(s). The aim of this study was to evaluate the usefulness of ¹⁸F-fluorocholine PET/CT for preoperative localization of hyperfunctioning parathyroid tissue.

Methods

¹⁸F-Fluorocholine PET/CT and conventional parathyroid scintigraphic imaging consisting of ^99mTc-sestaMIBI SPECT/CT, ^99mTc-sestaMIBI dual-phase imaging and ^99mTc-sestaMIBI/pertechnetate subtraction imaging were performed in 24 patients. The diagnostic performance of the imaging methods was compared against histology as the gold standard and postoperative serum Ca²⁺ and iPTH values.

Results

The sensitivity and specificity of ¹⁸F-fluorocholine PET/CT were 92 % and 100 %, respectively, in contrast to 49 % and 100 %, 46 % and 100 %, and 44 % and 100 % for ^99mTc-sestaMIBI SPECT/CT, ^99mTc-sestaMIBI/pertechnetate subtraction imaging and ^99mTc-sestaMIBI dual-phase imaging, respectively. Combined conventional scintigraphic imaging had a sensitivity and specificity of 64 % and 100 %, respectively. The performance of ¹⁸F-fluorocholine PET/CT was superior particularly in patients with multiple lesions or hyperplasia.

Conclusion

¹⁸F-Fluorocholine PET/CT appears to be a promising, effective imaging method for localization of hyperfunctioning parathyroid tissue.

Lew JI, Solorzano CC. Surgical management of primary hyperparathyroidism: state of the art. Surg Clin N Am. 2009;89:1205–25.PubMedCrossRef

Johnson NA, Carty SE, Tublin ME. Parathyroid imaging. Radiol Clin N Am. 2011;49:489–509.PubMedCrossRef

Taieb D, Hindie E, Grassetto G, Colletti PM, Rubello D. Parathyroid scintigraphy: when, how, and why? A concise systematic review. Clin Nucl Med. 2012;37(6):568–74.PubMedCrossRef

Grassetto G, Alavi A, Rubello D. PET and parathyroid. PET Clin. 2008;2:385–93.CrossRef

Treglia G, Giovannini E, Di Franco D, Calcagni ML, Rufini V, Picchio M, et al. The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review. Ann Nucl Med. 2012;26:451–61.PubMedCrossRef

Jadvar H. Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline. J Nucl Med. 2011;52:81–9.PubMedCrossRefPubMedCentral

Ishizuka T, Kajita K, Kamikubo K, Komaki T, Miura K, Nagao S, et al. Phospholipid/Ca2+-dependent protein kinase activity in human parathyroid adenoma. Endocrinol Jpn. 1987;34:965–8.PubMedCrossRef

Neumann DR, Esselstyn Jr CB, MacIntyre WJ, Chen EQ, Go RT, Kohse LM, et al. Primary hyperparathyroidism: preoperative parathyroid imaging with regional body FDG PET. Radiology. 1994;192:509–12.PubMedCrossRef

Neumann DR, Esselstyn CB, Maclntyre WJ, Go RT, Obuchowski NA, Chen EQ, et al. Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism. J Nucl Med. 1996;37:1809–15.PubMed

10.

Sisson JC, Thompson NW, Ackerman RJ, Wahl RL. Use of 2-[F-18]-fluoro-2-deoxy-D-glucose PET to locate parathyroid adenomas in primary hyperparathyroidism. Radiology. 1994;192:280.PubMedCrossRef

11.

Melon P, Luxen A, Hamoir E, Meurisse M. Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism. Eur J Nucl Med. 1995;22:556–8.PubMedCrossRef

12.

Herrmann K, Takei T, Kanegae K, Shiga T, Buck AK, Altomonte J, et al. Clinical value and limitations of [11C]-methionine PET for detection and localization of suspected parathyroid adenomas. Mol Imaging Biol. 2009;11:356–63.PubMedCrossRef

13.

Tang BN, Moreno-Reyes R, Blocklet D, Corvilain B, Cappello M, Delpierre I, et al. Accurate pre-operative localization of pathological parathyroid glands using 11C-methionine PET/CT. Contrast Media Mol Imaging. 2008;3:157–63.PubMedCrossRef

14.

Lange-Nolde A, Zajic T, Slawik M, Brink I, Reincke M, Moser E, et al. PET with 18F-DOPA in the imaging of parathyroid adenoma in patients with primary hyperparathyroidism. A pilot study. Nuklearmedizin. 2006;45:193–6.PubMed

15.

Hindié E, Ugur O, Fuster D, O’Doherty M, Grassetto G, Ureña P, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009;36:1201–16.PubMedCrossRef

16.

Nichols KJ, Tomas MB, Tronco GG, Rini JN, Kunjummen BD, Heller KS, et al. Preoperative parathyroid scintigraphic lesion localization: accuracy of various types of readings. Radiology. 2008;248:221–32.PubMedCrossRef

Title: 18F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study
Authors: Luka Lezaic
Sebastijan Rep
Mojca Jensterle Sever
Tomaz Kocjan
Marko Hocevar
Jure Fettich
Publication date: 01-11-2014
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 11/2014
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-014-2837-0

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

¹⁸F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2014

Prognostic value of tumour blood flow, [18F]EF5 and [18F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy

Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer

EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)

Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys

Impact of 18F-FDG PET/CT on the management of adrenocortical carcinoma: analysis of 106 patients

Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma